Today the Coalition for Epidemic Preparedness Innovations (CEPI) announced an award of $5 million funding award to Ethris, a ...

O n Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA vaccines in humans. The bill was sponsored by State Representative Greg Kmetz ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Request To Download Free Sample of This Strategic Report@ Highlighted with 59 tables and 54 figures, this 141-page report ?Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, ...

For each region and country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of all regional markets by country and the breakdown of each national market by ...

This acquisition is set to enhance the capabilities of Maravai's subsidiary, TriLink BioTechnologies, particularly in the field of mRNA and CRISPR nucleic acid-based therapies manufacturing. Molecular ...

(RTTNews) - The U.S. Food and Drug Administration has approved AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) ENHERTU (fam-trastuzumab deruxtecan-nxki) for the treatment of adult ...

As­traZeneca says it plans to par­tic­i­pate in the next round of Medicare ne­go­ti­a­tions un­der the In­fla­tion Re­duc­tion Act. But this time around, the com­pa­ny says … ...

Oracle Chairman Larry Ellison highlighted the potential medical benefits of the investment, stating that AI could be used to detect cancers and customize mRNA vaccines to treat them within 48 hours.

You can make that vaccine, that mRNA vaccine, you can make that robotically, again using AI, in about 48 hours." In the early hours as president, Trump nullified Biden-era executive orders ...